What Immunotherapy Actually Does & What It Can't Promise

Your Immune System Already Fights Cancer

Here's something most people don't realize: your immune system kills cancer cells every day. It's constantly scanning your body, identifying cells that look wrong, and destroying them before they become tumors. The problem isn't that your immune system can't fight cancer. The problem is that cancer learns to hide.

Cancer cells are sneaky. They develop ways to turn off your immune response, to essentially become invisible. They put up molecular stop signs that tell your T-cells to back off. And for decades, we had no way to tear those stop signs down.

That changed with immunotherapy. According to the National Cancer Institute, immunotherapy works by helping your immune system recognize and attack cancer cells more effectively. It's not adding something foreign to your body. It's removing the brakes that cancer put on your own defenses.

The Different Ways Immunotherapy Works

Not all immunotherapy is the same. There are several approaches, and understanding the differences matters when you're trying to figure out what might be relevant to your situation.

Checkpoint inhibitors are probably the most talked-about type right now. These drugs block the proteins that cancer uses to hide from your immune system. Drugs like nivolumab (Opdivo) and ipilimumab (Yervoy) fall into this category. In January 2025, the FDA approved using these two drugs together as a first treatment for certain advanced colorectal cancers that have specific genetic features called MSI-H or dMMR.

T-cell transfer therapy takes immune cells from your tumor, grows them in large numbers in a lab, and puts them back in your body. Think of it as training and multiplying your own soldiers. Recent research has shown promise with personalized approaches that target specific mutations in individual patients' tumors, leading to tumor shrinkage in several metastatic cancers.

Monoclonal antibodies are lab-made proteins that attach to specific targets on cancer cells, marking them for destruction. Treatment vaccines train your immune system to attack cancer cells. Immune system modulators boost your overall immune response. Each has different applications, different side effects, and different levels of evidence behind them.

The Honest Truth About Results

Here's where I have to be straight with you: immunotherapy works remarkably well for some people and not at all for others. There's no way to sugarcoat this.

Some patients have responses that last years. The colorectal cancer trial I mentioned earlier showed that combination immunotherapy improved progression-free survival compared to chemotherapy alone. That's real progress. But it worked specifically for cancers with certain genetic features, and even then, not everyone responded.

There's growing evidence that for some early-stage cancers, short courses of immunotherapy before surgery can produce dramatic tumor regression. Researchers are asking whether some patients might be able to skip or reduce surgery and chemotherapy altogether. But these approaches are still investigational. They need validation in larger, longer-term studies before becoming standard practice.

What we don't fully understand yet is why one person responds and another doesn't. Researchers are working on better ways to predict who will benefit, but we're not there yet.

Side Effects Are Real and Different

Because immunotherapy revs up your immune system, it can sometimes rev it up too much. Your immune system might start attacking healthy tissue, not just cancer. This is fundamentally different from chemotherapy side effects.

Common issues include fatigue, skin reactions, and inflammation in various organs. Some people develop thyroid problems or intestinal inflammation. In rare cases, the immune response can affect the heart, lungs, or other vital organs. The American Cancer Society notes that side effect profiles vary significantly depending on the type of immunotherapy used.

One particularly complicated situation involves patients who already have autoimmune diseases like rheumatoid arthritis, lupus, or Crohn's disease. For years, these patients were excluded from immunotherapy trials because doctors worried about triggering dangerous flares. An NCI-sponsored clinical trial is now studying whether checkpoint inhibitors can be safely used in people with both cancer and preexisting autoimmune conditions. This matters because it could open doors for patients who've been told immunotherapy isn't an option for them.

Finding Clinical Trials

If you're interested in immunotherapy, clinical trials might offer access to treatments not yet widely available. The National Cancer Institute maintains a searchable database of active immunotherapy trials that you can filter by cancer type, trial phase, and location.

Understanding how clinical trials work is important before you consider joining one. They're divided into phases, each with different goals. Phase 1 trials test safety and dosing in small groups. Phase 2 trials look at effectiveness. Phase 3 trials compare new treatments to current standards. Each phase has different levels of evidence and different risk profiles.

Trials aren't right for everyone. They often require frequent visits, extra tests, and strict protocols. But for some patients, they offer access to promising treatments and contribute to knowledge that helps future patients.

Questions Worth Asking Your Doctor

If immunotherapy comes up in conversations with your oncologist, here are questions that might help clarify whether it's relevant to your situation:

• Has my tumor been tested for biomarkers that predict immunotherapy response?

• What specific type of immunotherapy are you recommending, and why?

• What response rates have been seen in people with my specific situation?

• What side effects should I watch for, and how will we manage them?

• Are there clinical trials I should know about?

• If I have another health condition, does that change whether immunotherapy is an option?

Your oncologist should be able to answer these questions or refer you to someone who can. If they dismiss your questions or seem annoyed by them, that tells you something too.

The Bigger Picture

Immunotherapy represents a genuine shift in how we treat cancer. It's not hype. The science is real, and for some patients, the results have been life-changing.

But it's also not a miracle cure. It doesn't work for every cancer type. It doesn't work for every patient. And we're still learning who benefits most and why.

What matters is that you have accurate information so you can have real conversations with your care team. You deserve to know what's possible, what's proven, and what's still being figured out. That's the foundation for making decisions that are right for you.

References

1. Immunotherapy for Cancer - National Cancer Institute

2. FDA Approval Likely to Change Initial Treatment for Some People with Advanced Colorectal Cancer - National Cancer Institute

3. Personalized Immunotherapy Shrinks Solid Tumors - National Cancer Institute

4. Is Immunotherapy the Only Treatment Some People Need? - National Cancer Institute

5. What Is Immunotherapy? - American Cancer Society

6. Immunotherapy in People with Cancer and Autoimmune Diseases - National Cancer Institute

7. Clinical Trials Using Immunotherapy - National Cancer Institute

8. Cancer Clinical Trials Information for Patients and Caregivers - National Cancer Institute

Topics: